Mayne Pharma | MYX - Assets



Mayne Pharma reported AUD1.14B in Assets for its fiscal semester ending in June of 2024.


Assets Change Date
Ansell USD 3.24B 717.4M Jun/2024
Avita Medical AUD 79.71M 8.12M Dec/2024
Cochlear AUD 2.79B 41M Dec/2024
CSL USD 38.45B 425M Dec/2024
Healius AUD 3.07B 84.2M Dec/2024
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Nanosonics AUD 255.03M 17.69M Dec/2024
Next Science USD 9.21M 2.61M Dec/2024
Polynovo AUD 108.72M 11.51M Jun/2024
Ramsay Health Care AUD 20.66B 237M Dec/2024
ResMed USD 8.17B 1.03B Jun/2025
Sigma Healthcare AUD 1.7B 324.84M Jul/2024
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Telix Pharmaceuticals AUD 1.52B 770.47M Dec/2024